Literature DB >> 7513994

Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.

A R Baydoun1, G E Mann.   

Abstract

Amino acid transport systems mediating uptake of nitric oxide (NO) synthase inhibitors were characterized in the murine macrophage cell line J774. Treatment of J774 cells with bacterial endotoxin (LPS, 1 microgram ml-1, 24 h) selectively increased the transport capacity for NG-monomethyl-L-[14C]arginine (L-NMMA), whereas transport of NG-nitro-L-[3H]arginine (L-NNA) was unaffected. Inhibition studies established that the cationic transport system y+ mediates uptake of L-arginine, L-NMMA and NG-iminoethyl-L-ornithine (L-NIO). A neutral transporter, with low substrate specificity and insensitive to LPS, mediates uptake of L-citrulline, L-NNA and its methyl ester L-NAME. We conclude that enhanced expression of the y+ transporter in LPS-stimulated macrophages may facilitate the targeting of selective inhibitors of inducible NO synthase to activated cells generating NO in endotoxin shock.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513994     DOI: 10.1006/bbrc.1994.1511

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1.

Authors:  Matthew Lluis; Yun Wang; Arthur F Monzingo; Walter Fast; Jon D Robertus
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

2.  Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation.

Authors:  H G Bohlen; X Zhou; J L Unthank; S J Miller; R Bills
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

3.  Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.

Authors:  Yun Wang; Arthur F Monzingo; Shougang Hu; Tera H Schaller; Jon D Robertus; Walter Fast
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

4.  Na+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+).

Authors:  T Hatanaka; T Nakanishi; W Huang; F H Leibach; P D Prasad; V Ganapathy; M E Ganapathy
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

5.  Transport of N(G)-nitro-L-arginine across intestinal brush border membranes by Na+ -dependent and Na+-independent amino acid transporters.

Authors:  T Hatanaka; Y Nabuchi; H Ushio
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

6.  CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages.

Authors:  D K Kakuda; M J Sweet; C L Mac Leod; D A Hume; D Markovich
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

7.  Nitric oxide synthase activity and non-adrenergic non-cholinergic relaxation in the rat gastric fundus.

Authors:  D Currò; A R Volpe; P Preziosi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

8.  Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.

Authors:  S Pfeiffer; E Leopold; K Schmidt; F Brunner; B Mayer
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 9.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

10.  Diabetes-induced activation of system y+ and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization.

Authors:  L Sobrevia; P Cesare; D L Yudilevich; G E Mann
Journal:  J Physiol       Date:  1995-11-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.